Next, to investigate and compare the expression of known vascular cell markers we examined the gene expression of VE-cadherin and Ephrin type-A receptor 2 (EphA2) in the ECs and VM-competent cancer cells (breast and pancreatic). This evidence concerns the gene CDH5 and cancer.